Suchergebnisse - "YO603Y8113"

PubPharm (1.117)

91

Cardiovascular risks associated with protease inhibitors for the treatment of HIV

enthalten in: Expert opinion on drug safety | 2021

von Hatleberg, C. | Ryom, L. | Sabin, C.

92

Changes in Body Mass Index Associated with Antiretroviral Regimen Switch Among Treatment-Experienced, Virologically Suppressed People Living with HIV in the United States

enthalten in: AIDS research and human retroviruses | 2021

von Mounzer, K. | Brunet, L. | Hsu, R. | +7

93

Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders

enthalten in: ACS chemical neuroscience | 2021

von Latronico, T. | Rizzi, F. | Panniello, A. | +10

94

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2

enthalten in: Cells | 2021

von Rinaldi, R. | Miglionico, R. | Nigro, I. | +9

95

Implications of phase solubility/miscibility and drug-rich phase formation on the performance of co-amorphous materials : The case of Darunavir co-amorphous materials with Ritonavir and Indomethacin as co-formers

enthalten in: International journal of pharmaceutics | 2021

von Shete, S. | Reddy, S. | Lakshman, Y. | +4

96

Clinical efficacy of antiviral agents against coronavirus disease 2019 : A systematic review of randomized controlled trials

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2021

von Lai, C. | Chao, C. | Hsueh, P.

97

COVID-19 Outbreak in Italy : Report on the First 124 Consecutive Patients Treated at Home

enthalten in: The Tohoku journal of experimental medicine | 2021

von Cavanna, L. | Cremona, G. | Citterio, C. | +11

98

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

enthalten in: AIDS research and therapy | 2021

von Wolf, E. | Boesecke, C. | Balogh, A. | +9

99

Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients

enthalten in: Journal of medical virology | 2021

von Manganotti, P. | Bellavita, G. | Tommasini, V. | +8

100

Novel HIV PR inhibitors with C4-substituted bis-THF and bis-fluoro-benzyl target the two active site mutations of highly drug resistant mutant PRS17

enthalten in: Biochemical and biophysical research communications | 2021

von Agniswamy, J. | Kneller, D. | Ghosh, A. | +1